Song Yang

Title: The Innovations of Song Yang

Introduction

Song Yang is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of plasma kallikrein inhibitors. His work focuses on creating compounds that can effectively treat various disease states.

Latest Patents

Song Yang holds a patent for plasma kallikrein inhibitors. The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds. These compounds are designed for treating or preventing conditions that could benefit from the inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age-related macular edema, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.

Career Highlights

Song Yang is currently employed at Merck Sharp & Dohme Corp., where he continues to innovate in the pharmaceutical industry. His work has the potential to significantly impact the treatment of various eye and blood-related conditions.

Collaborations

He collaborates with notable professionals in his field, including his coworker Salman Jabri. Their combined expertise contributes to the advancement of research and development in their area of specialization.

Conclusion

Song Yang's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments that can improve patient outcomes.